Skip to content
Cryptos: 650Market Cap: $2.83T 1.1%24h Vol: $121.42BDominance: BTC 43.1% ETH 7.4%
Open Tradzy

New low · Australia stocks

Mesoblast Limited (MSB) closes at a 52-week low of AUD 1.70

Its second new 52-week low in 5 sessions. Down 7.6% over 20 sessions.

Published 19 November 2026 · Written from Tradzy's price and volume data

Close
AUD 1.70
On the day
−4.5%
Volume
1.5× average
vs 52-week high
−44.6%

Mesoblast Limited closing prices

AUD 1.75AUD 2.00AUD 2.25AUD 2.50Jul '26Aug '26Sep '26Sep '26Oct '26Nov '26AUD 1.70

The last 90 closes up to 19 November 2026. The live chart is on the MSB page.

What happened

Mesoblast Limited (MSB) closed at AUD 1.70 on 19 November 2026, down 4.5% from AUD 1.77 the session before.

It was the seventh lower close in a row. It is the second new low in the last 5 sessions. Over 5 sessions the price is down 13.9%, and over 20 sessions it is down 7.6%.

That close is below every close of the past year. The previous lowest was AUD 1.78 on 18 Nov 2026, and the new close is 4.5% under it.

Volume was close to its recent average.

Across the 25 CBOEAU stocks we track, 5 closed higher and 18 closed lower that day, with a median change of −2.06%. MSB's change was −4.5%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeAUD 1.77
CloseAUD 1.70
Change on the day−4.51%
Change over 5 sessions−13.85%
Change over 20 sessions−7.63%
Volume1.39 Million
Average volume, up to 20 sessions before950,865
Volume against that average1.5 times
Highest close in the past yearAUD 3.06 (9 Jan 2026)
Lowest close in the past yearAUD 1.78 (18 Nov 2026)

The full chart and history are on Mesoblast Limited (MSB). More from this market: CBOEAU news today.

More CBOEAU moves on 19 November 2026

Want a plan for MSB? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.